Post by Dr. Stefan Pabst

Analytic Translator in Customer Experience Excellence @ Daiichi Sankyo Deutschland GmbH | ex-TUM | Doktor der Wirtschaftswissenschaften

๐—ช๐—ต๐˜† ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ๐—ฒ๐—ฟ๐˜€๐—ต๐—ถ๐—ฝ ๐— ๐—ฎ๐˜๐˜๐—ฒ๐—ฟ๐˜€ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—ง๐—ต๐—ฎ๐—ป ๐—˜๐˜ƒ๐—ฒ๐—ฟ ๐—ถ๐—ป ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐—ฆ๐—ฎ๐—น๐—ฒ๐˜€ ๐Ÿญ/๐Ÿฏ The pharmaceutical industry operates under extreme constraints: strict regulation, limited promotion channels, short windows to recover massive R&D investments, and geopolitical challenges. In this environment, one question becomes critical: ๐˜ž๐˜ฉ๐˜ข๐˜ต ๐˜ณ๐˜ฆ๐˜ข๐˜ญ๐˜ญ๐˜บ ๐˜ฅ๐˜ณ๐˜ช๐˜ท๐˜ฆ๐˜ด ๐˜ด๐˜ข๐˜ญ๐˜ฆ๐˜ด ๐˜ฑ๐˜ฆ๐˜ณ๐˜ง๐˜ฐ๐˜ณ๐˜ฎ๐˜ข๐˜ฏ๐˜ค๐˜ฆ? A recent study from Amelie Tara Dittmann and me shows that leadership is not just an HR topic but a core business lever. Using a combination of expert interviews and personality analysis, the research examined how managers influence performance in sales. The key insight: ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ๐—ฒ๐—ฟ๐˜€๐—ต๐—ถ๐—ฝ ๐—ฒ๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐—ป๐—ฒ๐˜€๐˜€ ๐—ฑ๐—ถ๐—ฟ๐—ฒ๐—ฐ๐˜๐—น๐˜† ๐—ถ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜๐˜€ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐˜€๐˜‚๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€, ๐—ฒ๐˜€๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ฎ๐—น๐—น๐˜† ๐—ถ๐—ป ๐—ฑ๐—ฒ๐—ฐ๐—ฒ๐—ป๐˜๐—ฟ๐—ฎ๐—น๐—ถ๐˜‡๐—ฒ๐—ฑ, ๐—ต๐—ถ๐—ด๐—ต-๐—ฎ๐˜‚๐˜๐—ผ๐—ป๐—ผ๐—บ๐˜† ๐˜€๐—ฎ๐—น๐—ฒ๐˜€ ๐˜๐—ฒ๐—ฎ๐—บ๐˜€. But here's the twist: โœ–๏ธ It's ๐˜ฏ๐˜ฐ๐˜ต primarily about KPIs, targets, or incentives. โœ… It's about ๐˜ฉ๐˜ฐ๐˜ธ ๐˜ญ๐˜ฆ๐˜ข๐˜ฅ๐˜ฆ๐˜ณ๐˜ด ๐˜ฆ๐˜ฏ๐˜จ๐˜ข๐˜จ๐˜ฆ ๐˜ธ๐˜ช๐˜ต๐˜ฉ ๐˜ฑ๐˜ฆ๐˜ฐ๐˜ฑ๐˜ญ๐˜ฆ. This challenges a long-standing assumption in sales organizations: That performance can be managed mainly through metrics and control. In reality, metrics are just the starting point. ๐Ÿ‘‰ The real differentiation happens in human interaction. ๐Ÿ’ฌ Teaser for Part 2: What type of leadership actually drives performance?